About Us
Advances in research, digital, and data are creating more opportunities than ever before to improve patient outcomes. Investment in healthcare services is creating huge market opportunities.
We bring deep sectoral insight to the unique commercial, policy and regulatory challenges that this requires. We help clients value assets more accurately, drive uptake more speedily, and grow markets more sustainably.
Newmarket’s experts bring unrivalled experience in market access, gained through roles in the life sciences industry, government, reimbursement agencies, health systems and clinical practice
Launched in 2021, Newmarket Strategy is a first in class consultancy for the health and life sciences industry. Our unique application of policy, commercial and technical experience ensures our clients earn better commercial returns and patients get earlier access to innovative treatments.
Meanwhile, our exposure across pharmaceuticals, diagnostics, med tech, service provision and health data means we understand the opportunities and complexities in healthcare more deeply. We are proud to work with the world’s largest and most innovative life sciences companies, many of whom we have supported for several years with our various capabilities.
At the interface of healthcare systems and industry partners, our insights help unlock “win:win” agreements which benefit patients and shareholders. We have supported more than 150 clients – creating successful commercial strategies, influencing system policies and securing reimbursement for more than 600 individual assets.
What our clients say about working with Newmarket:
Newmarket provides that unique insight, and they’re able to see both sides of the equation: pharma on one side and government on the other. No one else has that perspective they can bring to us.
Market Access Director, global pharmaceuticals
The Newmarket team understand how it ticks. They offer not just an opinion, but advice. There is a difference.
CEO, UK Healthcare Provider
We are more prepared for what’s coming instead of being caught reacting.
UK General Manager, pharmaceuticals
They will tell us what’s going to work and what’s not going to work. They will distil things down to what we really need to hear and work on.
Government Affairs Director, UK life sciences
We get to the answer quickly – even with big decisions – without wasting a lot of effort, time and resources.
Market Access Director, UK life sciences
Their greatest strength is their interconnective knowledge of the UK market, whether it’s the government bodies or NHS. They understand the factors of the complex pathway dynamics.
Investment Director, global private equity
They have a tight team and an incredibly high standard of knowledge and expertise. When they recruit, they are recruiting outstanding individuals.
Managing Director, UK corporate